MOLECULAR AND CLINICAL CORRELATIONS IN SPINOCEREBELLAR ATAXIA TYPE-3 AND MACHADO-JOSEPH DISEASE

被引:86
|
作者
MATILLA, T
MCCALL, A
SUBRAMONY, SH
ZOGHBI, HY
机构
[1] BAYLOR COLL MED,DEPT PEDIAT,HOUSTON,TX 77030
[2] BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030
[3] UNIV MISSISSIPPI,MED CTR,DEPT NEUROL,JACKSON,MS 39216
关键词
D O I
10.1002/ana.410380113
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The autosomal dominant spinocerebellar ataxias are clinically and genetically a heterogeneous group of neurodegenerative disorders. Genetic studies have classified some of these disorders based on the mapping of their respective genes. The gene for Machado-Joseph disease, one type of spinocerebellar ataxia, has been mapped to the long arm of chromosome 14q24.3-ter. The gene for another spinocerebellar ataxia, which is clinically distinct from Machado-Joseph disease, has been also localized to the same region on 14q and has been named type 3 spinocerebellar ataxia Recently, expansions of a CAG trinucleotide repeat in a novel gene on chromosome 14q32.1 were shown in 11 patients affected with Machado-Joseph disease. In this study, we analyzed the DNA samples from 103 individuals representing 42 independent families with dominantly inherited ataxia to determine whether any had the Machado-Joseph disease mutation. The Machado-Joseph disease CAG expansion was detected in 5 of these 42 families. Sixteen affected individuals displayed a normal allele containing 14 to 31 CAG repeats and an expanded allele ranging between 66 and 79 CAG repeats. Seven asymptomatic individuals showed an allele ranging between 67 and 80 CAG repeats. Two of these families had a phenotype consistent with Machado-Joseph disease while the other 3 had clinical features of type 3 spinocerebellar ataxia. These data suggest that a single locus at 14q32.1 is responsible for two forms:of spinocerebellar ataxia, spinocerebellar ataxia type 3 and Machado-Joseph disease, and that this locus may account for approximately 11% of this group of dominantly inherited ataxias.
引用
收藏
页码:68 / 72
页数:5
相关论文
共 50 条
  • [21] Fatigue and Its Associated Factors in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
    Martinez, Alberto R. M.
    Nunes, Marcelo B.
    Faber, Ingrid
    D'Abreu, Anelyssa
    Lopes-Cendes, Iscia
    Franca, Marcondes C., Jr.
    CEREBELLUM, 2017, 16 (01): : 118 - 121
  • [22] Fatigue and Its Associated Factors in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
    Alberto R. M. Martinez
    Marcelo B. Nunes
    Ingrid Faber
    Anelyssa D’Abreu
    Íscia Lopes-Cendes
    Marcondes C. França
    The Cerebellum, 2017, 16 : 118 - 121
  • [23] Degeneration of the external cuneate nucleus in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Rüb, U
    de Vos, RAI
    Brunt, ER
    Schultz, C
    Paulson, H
    Del Tredici, K
    Braak, H
    BRAIN RESEARCH, 2002, 953 (1-2) : 126 - 134
  • [24] Machado-Joseph disease (Spinocerebellar ataxia type 3) and parasomnias: Correlation through polysomnography
    Pedroso, J. L.
    Silva, G. M. F.
    Santos, D. F.
    Prado, L. B. F.
    Carvalho, L. B.
    Barsottini, O.
    Prado, G. F.
    MOVEMENT DISORDERS, 2014, 29 : S479 - S480
  • [25] Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease
    de Assis, Adriano M.
    Morales Saute, Jonas Alex
    Longoni, Aline
    Haas, Clarissa Branco
    Torrez, Vitor Rocco
    Brochier, Andressa Wigner
    Souza, Gabriele Nunes
    Furtado, Gabriel Vasata
    Gheno, Tailise Conte
    Russo, Aline
    Monte, Thais Lampert
    Castilhos, Raphael Machado
    Schumacher-Schuh, Artur
    D'Avila, Rui
    Donis, Karina Carvalho
    de Mello Rieder, Carlos Roberto
    Souza, Diogo Onofre
    Camey, Suzi
    Leotti, Vanessa Bielefeldt
    Jardim, Laura Bannach
    Portela, Luis Valmor
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [26] Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease
    Hou, Xiaocan
    Gong, Xuan
    Zhang, Longbo
    Li, Tianjiao
    Yuan, Hongyu
    Xie, Yue
    Peng, Yun
    Qiu, Rong
    Xia, Kun
    Tang, Beisha
    Jiang, Hong
    EPIGENOMICS, 2019, 11 (09) : 1037 - 1055
  • [27] Botulinum toxin type a for treatment of spasticity in spinocerebellar ataxia type 3 (Machado-Joseph disease)
    Freeman, W
    Wszolek, Z
    MOVEMENT DISORDERS, 2005, 20 (05) : 644 - 644
  • [28] Extracellular Vesicle-Based Delivery of Silencing Sequences for the Treatment of Machado-Joseph Disease | Spinocerebellar Ataxia Type-3
    Rufino-Ramos, David
    Leandro, Kevin
    Carmona, Vitor
    Martins, Ines
    Albuquerque, Patricia
    Fernandes, Rita
    Henriques, Carina
    Lobo, Diana
    Faro, Rosario
    Perfeito, Rita
    Mendonca, Liliana
    Pereira, Dina
    Nobre, Rui J.
    de Almeida, Luis Pereira
    MOLECULAR THERAPY, 2023, 31 (04) : 346 - 346
  • [29] Spinocerebellar ataxia type 3 (Machado-Joseph disease):: severe destruction of the lateral reticular nucleus
    Rüb, U
    de Vos, RAI
    Schultz, C
    Brunt, ER
    Paulson, H
    Braak, H
    BRAIN, 2002, 125 : 2115 - 2124
  • [30] Towards the Identification of Molecular Biomarkers of Spinocerebellar Ataxia Type 3 (SCA3)/Machado-Joseph Disease (MJD)
    Lima, Manuela
    Raposo, Mafalda
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 309 - 319